Publicacións en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (28)

2020

  1. Andrología y cáncer de pene. Recomendaciones durante la pandemia COVID-19

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 395-404

  2. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis

    Neurourology and Urodynamics, Vol. 39, Núm. 2, pp. 762-770

  3. Fe de errores a «Profilaxis farmacológica de la tromboembolia venosa en la prostatectomía radical» [Med Clin (Barc). 2020;154(4):113–118] (Medicina Clinica (2020) 154(4) (113–118), (S0025775319303513), (10.1016/j.medcli.2019.04.023))

    Medicina Clinica

  4. Impact of organ confined prostate cancer treatment on quality of life

    Actas Urologicas Espanolas, Vol. 44, Núm. 9, pp. 630-636

  5. Incidence of upper tract urothelial carcinoma in Spain

    Actas Urologicas Espanolas, Vol. 44, Núm. 7, pp. 512-518

  6. Long-term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study

    Neurourology and Urodynamics, Vol. 39, Núm. 6, pp. 1737-1745

  7. Manejo del paciente neurourológico durante la pandemia COVID-19

    Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 429-437

  8. Pharmacological venous thromboembolism prophylaxis in radical prostatectomy

    Medicina Clinica, Vol. 154, Núm. 4, pp. 113-118

  9. Position of the Ibero-American Society of Neurourology and Urogynecology in relation to the use of synthetic suburethral meshes for the surgical treatment of female stress incontinence

    Neurourology and Urodynamics, Vol. 39, Núm. 1, pp. 464-469

2019

  1. Current status of radiological protection in endourological procedures in Spain

    Actas Urologicas Espanolas, Vol. 43, Núm. 4, pp. 205-211

  2. Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study

    World Journal of Urology, Vol. 37, Núm. 10, pp. 2189-2197

  3. Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance

    Prostate Cancer and Prostatic Diseases, Vol. 22, Núm. 1, pp. 84-90